Lymph Node Metastasis in Breast Cancer: Treatment Options - Oncology

Share to:

Breast cancer metastasis to lymph nodes?


Doctor, I apologize for bothering you, but I have a question.
My wife has metastatic breast cancer that has spread to the lymph nodes and is resistant to treatment.
Can she receive mogamulizumab? Is it effective? Thank you, doctor.

A-Wen, 50~59 year old female. Ask Date: 2017/07/07

Dr. Hu Ziren reply Oncology


Mabthera (Rituximab) is ineffective.

Reply Date: 2017/07/07

More Info


Understanding lymph node metastasis in breast cancer is crucial for determining the appropriate treatment options. When breast cancer spreads to the lymph nodes, it indicates a more advanced stage of the disease, which can significantly influence treatment decisions and prognosis.

In your wife's case, the presence of lymph node metastasis suggests that the cancer has progressed beyond the primary tumor site. This typically necessitates a more aggressive treatment approach. The standard treatment for breast cancer with lymph node involvement often includes a combination of surgery, chemotherapy, radiation therapy, and possibly targeted therapies, depending on the specific characteristics of the cancer.

1. Chemotherapy: This is often recommended for patients with lymph node involvement, especially if the cancer is aggressive or if there are multiple nodes affected. Chemotherapy can help to eliminate any remaining cancer cells in the body after surgery. The regimen may include drugs like doxorubicin, cyclophosphamide, and taxanes, among others. The specific choice of drugs will depend on various factors, including the cancer's hormone receptor status and the patient's overall health.

2. Hormonal Therapy: If the cancer is hormone receptor-positive (ER+ or PR+), hormonal therapy may be an effective treatment option. This can include medications like tamoxifen or aromatase inhibitors, which help to block the effects of estrogen on breast cancer cells. This is particularly relevant if the cancer has shown resistance to other treatments.

3. Targeted Therapy: If the cancer is HER2-positive, targeted therapies such as trastuzumab (Herceptin) may be used. These therapies specifically target the HER2 protein, which can promote the growth of cancer cells. However, if your wife’s cancer has shown resistance to these treatments, it may require a reevaluation of her treatment plan.

4. Radiation Therapy: This is often used after surgery to eliminate any remaining cancer cells in the breast area and lymph nodes. It can be particularly important if there are multiple lymph nodes involved or if the tumor was large.

5. Clinical Trials: Given the complexity of treatment, especially in cases of drug resistance, participating in clinical trials may be an option worth considering. These trials often explore new therapies that may not yet be widely available but could offer additional treatment avenues.

Regarding your specific question about "莫須瘤" (which I assume refers to a specific treatment or drug), it’s essential to clarify what this treatment entails. If it is a new or experimental therapy, discussing its potential benefits and risks with your oncologist is crucial. They can provide insights into whether it is appropriate for your wife's specific situation and whether it has shown efficacy in similar cases.

In summary, the treatment of breast cancer with lymph node metastasis is multifaceted and should be tailored to the individual patient based on the cancer's characteristics and the patient's overall health. Close collaboration with an oncologist is vital to navigate the complexities of treatment options and to ensure the best possible outcome. Regular follow-ups and monitoring are also essential to assess the effectiveness of the treatment and to make necessary adjustments.

Similar Q&A

Understanding Recurrence in Early Stage Breast Cancer: Key Insights and Concerns

Hello, Doctor! I was diagnosed with breast cancer in November 2021 and underwent a right mastectomy with reconstruction. Post-surgery, it was found that there was a 0.1 cm invasive cancer in the lymph nodes with no metastasis, and the subtype was hormone receptor-positive. The do...


Dr. Chen Sirong reply Oncology
Evans, 43 years old, female. Due to the lack of personal insurance, the medical burden is really heavy. A: It is possible to choose treatment options covered by the National Health Insurance, but the general public tends to want to follow the doctor's advice if they can affo...

[Read More] Understanding Recurrence in Early Stage Breast Cancer: Key Insights and Concerns


Understanding Early Stage Breast Cancer: Treatment Options and Concerns

My mother has stage I breast cancer with a 1.4 cm tumor. After the doctor removed it and confirmed the diagnosis, the surgeon initially only removed half of the tumor, but at my mother's request, the remaining part was also removed. Will this cause the cancer cells to spread...


Dr. Zhao Ming reply Breast and Thyroid
1. Generally, this is a standard treatment approach and does not lead to the spread of breast cancer. 2. The survival rate for breast cancer primarily depends on the malignancy of the individual cancer cells rather than the treatment method (chemotherapy can improve survival ra...

[Read More] Understanding Early Stage Breast Cancer: Treatment Options and Concerns


Post-Chemotherapy Management for Breast Cancer Patients: Key Considerations

The patient has right breast cancer and has undergone a total mastectomy and axillary lymph node dissection. The pathology report indicates the following: Stage: IIB, Tumor size: 2.4 cm, Lymph nodes: positive for metastasis (2, 11), Distant metastasis: none, Tumor type: IDC ER: 9...


Dr. Chen Sirong reply Oncology
Patient: 46 years old, male 1. I would like to ask, what are the key reasons for the consultation with the radiologist to assess whether additional radiation therapy and oral chemotherapy are necessary? A: If the lymph nodes have not metastasized, and the tumor is less than 4 c...

[Read More] Post-Chemotherapy Management for Breast Cancer Patients: Key Considerations


Understanding Triple-Negative Breast Cancer: Risks, Treatments, and Prognosis

Hello Doctor, I would like to ask you a question regarding my mother, who is currently 61 years old. She was recently diagnosed with breast cancer (Luminal B type, grade 2) and has just undergone a partial mastectomy and sentinel lymph node biopsy (4 nodes), with no lymph node me...


Dr. Chen Sirong reply Oncology
Hello, 1. I would like to ask the doctor if the risk of recurrence for my mother is high. Using this algorithm, IHC4 = 32 > 30 indicates high risk, with ER = 90, PR = 90, Her2 = 1, and Ki67 = 30 for calculating the IHC4 score. 2. Since the doctor recommends both chemotherap...

[Read More] Understanding Triple-Negative Breast Cancer: Risks, Treatments, and Prognosis


Related FAQ

Lymph Node Cancer

(Oncology)

Lymphadenopathy

(Oncology)

Enlarged Lymph Nodes

(Oncology)

Cancer Treatment

(Oncology)

Axillary Lump

(Oncology)

Breast Adenoma

(Oncology)

Breast Cancer

(Surgery)

Neck

(Oncology)

Inguinal Lymphadenopathy

(Oncology)

Leukemia

(Oncology)